Torrent Pharmaceuticals has surged 5% to Rs 655 after reporting 119% year-on-year (yoy) jump in consolidated net profit at Rs 244 crore for the fourth quarter ended March 2014 (Q4FY14) on back of strong international revenues. The company had profit of Rs 111 crore in the corresponding quarter previous year.
Company’s revenues increased by 41% for the quarter at Rs 1,225 crore from Rs 871 crore in same period last year. International revenues grew by 69% yoy to Rs 887 crore, Torrent Pharma said in a statement.
EBITDA margins expanded 330 basis points on a yoy basis to 28.57% from 25.25% in previous year quarter.
Meanwhile, the board of the directors of the company has recommended dividend of Rs 5 per share for the year 2013-14.
The stock opened at Rs 670 and hit a record high of Rs 689 on the BSE. A combined 395,000 shares changed hands on the counter so far on the BSE and NSE.
Company’s revenues increased by 41% for the quarter at Rs 1,225 crore from Rs 871 crore in same period last year. International revenues grew by 69% yoy to Rs 887 crore, Torrent Pharma said in a statement.
EBITDA margins expanded 330 basis points on a yoy basis to 28.57% from 25.25% in previous year quarter.
Meanwhile, the board of the directors of the company has recommended dividend of Rs 5 per share for the year 2013-14.
The stock opened at Rs 670 and hit a record high of Rs 689 on the BSE. A combined 395,000 shares changed hands on the counter so far on the BSE and NSE.